Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 308.3 INR 0.85% Market Closed
Market Cap: 139.7B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Gross Margin
Marksans Pharma Ltd

53.4%
Current
52%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.4%
=
Gross Profit
12.1B
/
Revenue
22.7B

Gross Margin Across Competitors

Country IN
Market Cap 139.7B INR
Gross Margin
53%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 746.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 365.6B USD
Gross Margin
69%
Country US
Market Cap 249.1B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Marksans Pharma Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.4%
=
Gross Profit
12.1B
/
Revenue
22.7B
What is the Gross Margin of Marksans Pharma Ltd?

Based on Marksans Pharma Ltd's most recent financial statements, the company has Gross Margin of 53.4%.